Gliotoxin, a redox-active metabolite, is produced by the opportunistic fungal pathogen Aspergillus fumigatus, and its biosynthesis is directed by the gli gene cluster. Knowledge of the biosynthetic pathway to gliotoxin, which contains a disulfide bridge of unknown origin, is limited, although L-Phe and L-Ser are known biosynthetic precursors. Deletion of gliG from the gli cluster, herein functionally confirmed as a glutathione S-transferase, results in abrogation of gliotoxin biosynthesis and accumulation of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. This putative shunt metabolite from the gliotoxin biosynthetic pathway contains an intriguing hydroxyl group at C-6, consistent with a gliotoxin biosynthetic pathway involving thiolation via addition of the glutathione thiol group to a reactive acyl imine intermediate. Complementation of gliG restored gliotoxin production and, unlike gliT, gliG was found not to be involved in fungal self-protection against gliotoxin.
INTRODUCTION
The biosynthesis of fungal secondary metabolites frequently involves nonribosomal peptide synthetases and a range of associated enzymes that is often encoded by gene clusters (Maiya et al., 2006; Stack et al., 2007 ). An example of one such nonribosomal peptide made by fungi is the epipolythiodioxopiperazine (ETP), gliotoxin 1 (Figure 1 ), which contains a transannular disulfide bridge of unknown origin (Fox and Howlett, 2008) . Primarily due to the disulfide bridge, gliotoxin exhibits antimicrobial, immunosuppressive, and antiangiogenic properties, and its various biological activities have been the subject of significant investigation (Bernardo et al., 2003; Li et al., 2006; Choi et al., 2007) . It has also attracted attention as a biomarker of fungal disease and contaminated animal feedstuffs (Lewis et al., 2005; Pena et al., 2010) .
The gli biosynthetic cluster, which directs gliotoxin production in Aspergillus fumigatus, was identified in 2004 and is now known to contain 13 genes (Gardiner et al., 2004; Schrettl et al., 2010) .
Subsequent work showed that the coordinated expression of constituent genes was associated with gliotoxin production, and targeted disruption of the genes encoding a transcriptional regulator (gliZ) and a nonribosomal peptide synthetase (gliP) abolished gliotoxin biosynthesis in A. fumigatus (Gardiner and Howlett, 2005; Cramer et al., 2006; Bok et al., 2006; Kupfahl et al., 2006) . Biochemical studies of purified recombinant GliP demonstrate that it is capable of assembling an L-Phe-L-Ser dipeptidyl thioester intermediate tethered to a thiolation domain within the enzyme. This intermediate undergoes slow conversion to the corresponding diketopiperazine 2, which is probably the first free intermediate in gliotoxin biosynthesis (Balibar and Walsh, 2006) (Figure 1 ). Although the gene encoding the proposed ABC transporter export system for gliotoxin (gliA) has not been disrupted in A. fumigatus, deletion of an ortholog, sirA, in Leptosphaeria maculans surprisingly resulted in increased secretion of sirodesmin, an ETP structurally related to gliotoxin (Gardiner et al., 2005a) . The sirA mutant exhibited increased sensitivity to exogenous sirodesmin and gliotoxin, and expression of gliA from A. fumigatus in L. maculans DsirA conferred resistance to gliotoxin, but not sirodesmin. More recently, a flavin-dependent oxidoreductase, encoded by gliT within the gliotoxin biosynthetic gene cluster, has been shown to completely protect A. fumigatus against exogenous gliotoxin (Schrettl et al., 2010; Scharf et al., 2010) . Gliotoxin production was also abrogated in a gliT mutant of A. fumigatus and transformation of A. nidulans and Saccharomyces cerevisiae, respectively, with gliT conferred gliotoxin resistance on these gliotoxin-sensitive fungal species (Schrettl et al., 2010) . Biochemical studies with purified recombinant GliT show that it catalyzes transannular disulfide formation in the dithiol precursor 3, which is the final step in gliotoxin biosynthesis (Scharf et al., 2010) .
The role of other genes within the gliotoxin biosynthetic gene cluster, either in self-protection against, or biosynthesis of, gliotoxin, remains to be fully elucidated (Gardiner et al., 2005b) . In particular the origin and mechanism of incorporation of the sulfur atoms into gliotoxin are unclear. Although it has been demon- prenyl-L-tyrosine, and [5,5-2 H 2 ]phomamide can be incorporated into sirodesmin PL, it has not been possible to conclusively identify-by feeding studies with isotope-labeled precursors-the metabolic origin of the sulfur atoms in this ETP (Pedras and Yang, 2009 ). The diketopiperazine alkaloid (+)-11,11 0 -dideoxyverticillin A, which contains two transannular disulfide bridges, is produced by Penicillium sp. The total chemical synthesis of this ETP has recently been achieved (Kim et al., 2009) , in which late-stage treatment of a protected bis-dihydroxydiketopiperazine intermediate with K 2 CS 3 results in the formation of a dimeric bisdithiepanethione, in high yield, presumably via initial elimination of water to form an acyl iminium ion intermediate followed by addition of CS 3
2À
, resulting ultimately in the replacement of four C-O bonds with four C-S bonds. This study demonstrates that biosynthetic incorporation of sulfur into ETPs via diketopiperazine C-hydroxylation and subsequent elimination of water to form an acyl imine that undergoes addition of a thiol is chemically feasible.
The role of gliG (AFUA_6G09690; http://www.cadre-genomes. org.uk/) within the gli cluster, which in silico analysis predicts encodes a glutathione S-transferase (GST), is unclear. It could be involved in biosynthetic thiolation of an acyl imine intermediate or auto-protection against gliotoxin (Figure 1 ). Normally, GSTs catalyze conjugation of glutathione (GSH) to toxic (chemically reactive) metabolites to facilitate detoxification and cellular secretion. Although GSTs have received significant attention in mammalian and plant systems (Hayes et al., 2005; Dixon et al., 2010) , their presence and function in fungi have only recently been studied (Burns et al., 2005; Morel et al., 2009) . The lowpercentage sequence identity of GliG to other putative GSTs encoded within the A. fumigatus genome (Cramer et al., 2006 ) (approximately 30%) may indicate a function for GliG that is distinct from the other GSTs (Nierman et al., 2005) . To investigate the function of gliG in A. fumigatus, it was disrupted, and the phenotype of the mutant with respect to gliotoxin biosynthesis and auto-protection was examined.
RESULTS
Deletion and Complementation of gliG in A. fumigatus Homologous transformation using the bipartite marker technique , with modifications, was used to generate DgliG mutants in both A. fumigatus DakuB (da Silva Ferreira et al., 2006) and AF293 (Nierman et al., 2005) backgrounds. Here, the A. fumigatus strains were cotransformed with two DNA constructs, each containing an incomplete fragment of the pyrithiamine (ptrA) resistance gene (Kubodera et al., 2000) fused to 1.2 kb (5 0 ) and 1.0 kb (3 0 ) of gliG-flanking sequences (Figure 2 ). These constructs were generated by PCR and characterized by DNA sequence analysis that confirmed the replacement of gliG by overlapping ptrA regions on intact 5 0 and 3 0 -flanking regions, respectively. Southern analysis was used to screen 37 putative transformants for gliG (negative) and ptrA (positive) colonies with a 2124 bp XbaI restriction fragment in place of the wild-type 1668 bp XbaI restriction fragment (Figure 2 (Figure 3 ).
Phenotypic Analysis
Exposure of A. fumigatus wild-type and DgliG conidia to exogenous gliotoxin (10-50 mg/ml) showed that both strains grew equally well (Figure 4 ), thereby confirming that gliG does not play a role in self-resistance to gliotoxin. Observation of A. fumigatus wild-type and DgliG conidia in the presence of H 2 O 2 (1, 2, and 5 mM), voriconazole (0.15 and 0.25 mg/ml), and amphotericin B (1, 2, and 5 mg/ml) showed that both wild-type vector. An XbaI restriction enzyme was used to digest genomic DNA, which was probed with a 1.2 kb probe.
(B) Southern analysis of DgliG mutant versus wildtype DNA for A. fumigatus DakuB and AF293, respectively. Here, a DIG-labeled probe amplified using ogliG-3 and ogliG-6 for the 5 0 -flanking region was used to detect the predicted presence of 1.6 and 2.1 kb fragments in XbaI-digested genomic DNA from DgliG and wild-type, respectively. (C) Representation of the DgliG locus in complemented strains (gliG C ). A linearized plasmid (pgliG-phleomycin) was transformed into the DgliG locus. Genomic DNA of the complemented strains was digested with EcoRV, and probed using a 1 kb probe.
(D) Southern analysis of DgliG complemented strains (gliG C ). A DIG-labeled probe amplified using ogliG-4 and ogliG-5 for the 3 0 -flanking region was used to detect the presence of a 3.4 and 1.5 kb fragment in EcoRV-digested genomic DNA. Lanes 1 and 3 represent transformant Nos. 15 and 17, respectively. Both contain the predicted 3.4 and 1.5 kb fragments. These transformants were isolated as potential complemented strains and subjected to second-round Southern analysis to confirm this complementation. Lane 2 represents a transformant that was not deemed as complemented. Lane 4 is wild-type DNA that contains the predicted fragment of 1.5 kb. Lane 5 is DgliG DNA that was expected to contain neither the 3.4 or the 1.5 kb signal.
and mutant grew at identical rates (data not shown), thus excluding gliG involvement in protection against oxidative stress and antifungal agents. Exposure to conidia of A. fumigatus DgliG induced greater melanization in the Galleria mellonella virulence model (Reeves et al., 2004) compared to wild-type or gliG C (15.1, 15.4, and 17.1), although no statistical significance was observed in overall virulence among wild-type, mutant, or complemented strains (data not shown).
A. fumigatus DgliG Does Not Produce Gliotoxin
Organic extracts from 48-hr cultures of A. fumigatus wild-type, DgliG DakuB , DgliG AF293 , and gliG C were prepared and analyzed by LC-ToF MS ( Figure 5 ) and comparative RP-HPLC analysis (see Figure S1 available online). It is clear from Figure 5 that although gliotoxin was produced (mean ± SD: 784.9 ± 869.88 mg/ml) by A. fumigatus wild-type (retention time [R T ] = 14.8 min, Figure S1 ), no gliotoxin was detectable in organic extracts from the A. fumigatus DgliG strains. However, an alternative metabolite, termed M12.3, was evident in DgliG organic extracts, with R T = 12.3 min ( Figure 6 ). LC-ToF MS analysis also confirmed the restoration of gliotoxin production in gliG C (Figure 5) (range: 2244 ± 1622 mg/ml to 3158 ± 63.57 mg/ml). Sequential NaBH 4 reduction (Woodcock et al., 2001 ) and alkylation (5 0 -iodoacetamidofluorescein; 5 0 -IAF) of organic extracts from A. fumigatus wild-type, DgliG, and gliG C was undertaken. Gliotoxin was completely reduced to the dithiol form using sodium borohydride. The presence of di-acetamidofluorescein-gliotoxin (GT-(AF) 2 ) was evident in organic extracts from A. fumigatus wild-type ( Figure 5 ) and gliG C ( Figure S1 ). However, no 5 0 -IAF-labeled gliotoxin was detectable, with or without prior reduction, in organic extracts derived from A. fumigatus DgliG AF293 ( Figure 5 ). This confirmed the absence of free thiols or a disulfide bridge in M12.3 and suggested that GliG may play a role in the incorporation of sulfur atoms into gliotoxin. Figure 6D ). The compound is proposed to be 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 4 (Figure 1 Figure S3 ). We observed a d C value of 83.5 for C-6 of the compound that compares very favorably with reported d C values of 82.9 and 87.2 for the almost identical C-6 carbons in similar compounds (Buysens et al., 1996; King et al., 2003) . In the 1 H-NMR spectrum in CD 3 CN, the CONH proton signal at d H $7.23 overlaps with the signals due to the aromatic protons, but in CDCl 3 the CONH signal is shifted away from the aromatic signals to d H 7.50. This shift in the CONH signal allowed us to distinguish between structure 4 and an alternative structure with the methoxy group attached to N-4 rather than N-1. The COSY spectrum in CDCl 3 showed a clear coupling between the CONH signal at d H 7.50 and the methylene protons (C = CH 2 ) (Figure 1 ; Figure S6 ). This longrange coupling, over four bonds, indicated that the NH group was located at position 4, adjacent to the disubstituted alkene (location of the NH group at position 1 would require a five bond coupling to the methylene protons). In addition the HMBC correlation data obtained in CDCl 3 showed a coupling between the CONH proton signal at d H 7.50 and C-5/C-3, (Figure 1 and Table 1 ), which is consistent with structure 4. The alternative structure with the methoxy group at position 4 would be expected to show couplings between the CONH signal and C-2 and C-6 in the HMBC spectrum, which was not observed ( Figure S9 ). Finally, no deep-violet color was observed when a ferric chloride test for the presence of hydroxamic acids was performed (Shin et al., 1975) , confirming the absence of a hydroxamic acid group in the compound.
A Gliotoxin Biosynthetic
Feeding experiments with [3- Recombinant GliG Exhibits GST and Reductase Activity Protein expression plasmid pPXAgliG consisting of the vector pProEx-Htb containing the coding sequence for gliG was used to transform Escherichia coli DH5a, and expression was induced by the addition of 0.6 mM IPTG. rGliG was present in cell lysate pellet, indicating insolubility, and was purified using differential extraction, with a yield of approximately 12 mg/g of E. coli. SDS-PAGE analysis confirmed a molecular mass of 25 kDa for . Lanes 3-5 correspond to A. fumigatus RNA extracts from 48-hr AMM for three independent gliG-complemented strains. Equal RNA loading/track was shown by rRNA subunit presence. rGliG ( Figure S10 ). The identity of purified rGliG was confirmed by peptide mass fingerprinting. Several peptides corresponding to the theoretical protein sequence (26.5% sequence coverage; data not shown) were identified. Following large-scale overproduction, rGliG was solubilized and subjected to serial dialysis at 250 mg/ml, yielding 67% rGliG recovery (170 mg/ml). Post-dialysis, rGliG exhibited GST activity with 1,2-epoxy-3-(4-nitrophenoxy)-propane (EPNP Specific Activity [S. A.] [mean ± SD] = 2.3 ± 0.122 U/mg), 1-chloro-2,4-dinitrobenzene (CDNB S.A. = 0.20 ± 0.1 U/mg), and 3,4-dichloro-nitrobenzene (DCNB S.A. = 0.09 ± 0.001 U/mg). rGliG also exhibited glutathione reductase activity (S.A. = 0.01 ± 0.002 U/mg). Whole-protein lysates from A. fumigatus DgliG AF293 exhibited 17% less activity toward EPNP than those from A. fumigatus wild-type (S.A. = 0.12 ± 0.02 U/mg versus 0.145 ± 0.011 U/mg, respectively).
DISCUSSION
The biosynthetic pathway to gliotoxin has, before now, been unclear. Using a gene deletion strategy, our work has demonstrated that GliG, which exhibits GST activity and is encoded by a gene within the gli cluster, is essential for gliotoxin production in A. fumigatus. Furthermore, the absence of GliG results in the accumulation and secretion of the shunt metabolite 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 4, which lacks both of the sulfur atoms incorporated into the disulfide bridge of gliotoxin. Genetic complementation of the A. fumigatus gliG mutant restored gliotoxin production. Unlike some of the other genes in the gli cluster studied to date (e.g., gliT or gliA), gliG is not involved in the auto-protection of A. fumigatus against exogenous gliotoxin. Taken together, our data suggest that GliG is involved in the introduction of sulfur into 6-benzyl-6-hydroxy-3-hydroxymethylpiperazine-2,5-dione 5 (Figure 1) , the likely precursor of the shunt metabolite 4.
The gliG gene was deleted from both A. fumigatus AF293 and A. fumigatus DakuB in order to elucidate its function in gliotoxin metabolism, a strategy noted by others for the functional dissection of the gliotoxin biosynthetic pathway (Patron et al., 2007; Fox and Howlett, 2008) . Expression of gliG, along with other genes in the gli cluster, has been shown to be coincident with gliotoxin formation (Gardiner and Howlett, 2005) . Moreover, Cramer et al. (2006) demonstrated that low-level gliG expression was evident in the A. fumigatus DgliP (termed ARC2) that, along with other gli cluster components (except gliP), was upregulated upon exposure to gliotoxin (20 mg/ml) for 24 hr. This has led to the suggestion that gliotoxin plays a role in the regulation of its own biosynthesis. Cramer et al. (2006) also observed entire gli cluster expression in A. fumigatus wild-type (AF293) in the presence of gliotoxin (20 mg/ml). In the present work, northern analysis confirmed the presence and absence of gliG expression in A. fumigatus AF293 and DgliG AF293 , respectively, in the absence of added gliotoxin. However, gliotoxin addition was necessary to detect gliG expression in A. fumigatus DakuB wild-type, although no transcript was detectable in A. fumigatus DgliG akuB by northern analysis. Coincident with absence of gliG expression, both A. fumigatus DgliG strains generated in this work were unable to produce gliotoxin, although a gliotoxin-related shunt metabolite (M12.3) 4 was identified in both deletion strains. Disruption of gliP and gliZ, respectively, also abrogates gliotoxin production. However, no gliotoxin-related metabolites were detected in these studies (Cramer et al., 2006; Kupfahl et al., 2006) . Thus, our results extend the number of genes in the gli cluster confirmed to play a role in gliotoxin biosynthesis. Along with gliG expression, gliotoxin production was restored in A. fumigatus DgliG AF293 upon introduction of the entire gliG coding sequence. Interestingly, no gliG-complemented strains were recoverable from A. fumigatus DgliG disrupted in the akuB background. Bok et al. (2006) also observed restoration of gliotoxin production upon complementation of an . Absence of labeled gliotoxin was evident, as indicted by the asterisk. See also Figure S1 .
A. fumigatus gliZ mutant with the gliZ coding sequence. Moreover, complementation of a gliP mutant of A. fumigatus with gliP also restored gliotoxin biosynthesis and secretion (Cramer et al., 2006; Kupfahl et al., 2006) . Secreted metabolites may be involved in maintenance of competitive advantage against other fungi, and it has been speculated that toxin-resistance genes may exist in fungi to protect against the autotoxicity of such metabolites (Losada et al., 2009) . Given the role of GSTs in reactive metabolite detoxification in animals, plants, and fungi (Hayes et al., 2005; Dixon et al., 2010; Burns et al., 2005) , it was conceivable that gliG is involved in auto-protection against gliotoxin, as has previously been demonstrated by expression of A. fumigatus gliA in L. maculans (Gardiner et al., 2005a) . However, A. fumigatus DgliG AF293 did not exhibit increased sensitivity to gliotoxin compared to A. fumigatus wild-type. Thus, gliG, and most likely all orthologs found in other ascomycetes (Patron et al., 2007; Fox and Howlett, 2008) , does not appear to be primarily involved in self-protection against gliotoxin. This observation prompted us to investigate a role for gliG in gliotoxin biosynthesis.
Although Balibar and Walsh (2006) have shown that GliP can assemble 6-benzyl-3-hydroxymethylpiperazine-2,5-dione 2 (Figure 1 ) from L-Phe and L-Ser, it is unclear whether this diketopiperazine is an intermediate in gliotoxin biosynthesis. Indeed, to our knowledge, no free reaction intermediates in gliotoxin biosynthesis have been detected to date, as previously noted by Fox and Howlett (2008) . Herein we report that 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 4 accumulates in and is secreted by a gliG mutant of A. fumigatus. Based on the structural similarity of 4 to 1 and 2, it seems likely that 4 is a shunt metabolite from the gliotoxin biosynthetic pathway. We hypothesize that 6-benzyl-3-hydroxymethylpiperazine-2,5-dione 2 undergoes hydroxylation at C-6, catalyzed by the cytochrome P450s GliC or GliF to yield 5 (Figure 1) . Hydroxylation of 5 at N-1, catalyzed either by GliC/GliF or more likely a nonspecific monooxygenase not encoded by a gene within the gliotoxin biosynthetic gene cluster, followed by O-methylation, perhaps catalyzed by GliM, and elimination of water from C-3/C-7 would give the shunt metabolite 4 (Figure 1) . It is possible that N1 functionalization could be off pathway and be a self-protecting detoxification against the reactive intermediate. GliC/GliF-catalyzed hydroxylation of 5 at C-3 would afford 6, which can lose two molecules of water to yield the 2,5-pyrazinedione 7 (Figure 1 ). GliG-catalyzed addition of two molecules of glutathione to 7 would yield 8 (Figure 1 ). An alternative sequence of reactions involving two rounds of sequential C-hydroxylation, water elimination, and glutathione addition reactions on 2 to give 8 is equally plausible. GliJ, a putative dipeptidase, is proposed to catalyze hydrolytic removal of the Glu residues in 8 to give 9 (Figure 1 ). GliI is similar to pyridoxal phosphate (PLP)-dependent enzymes such as 1-aminocyclopropane-1-carboxylate (ACC) synthase, which catalyzes a pyridoxal-mediated 1, 3-elimination reaction of S-adenosylmethionine to form ACC and 5 0 -deoxy-5 0 -methylthioadenosine (Fox and Howlett, 2008) . The GliJ-mediated ''deprotection'' of the cysteine amino groups allows their condensation with GliI-bound PLP. Thus, we propose that GliI catalyzes two pyridoxal-mediated a, b-elimination reactions of 9 to afford 6-benzyl-3-hydroxymethylpiperazine-2,5-dione-3, 6-dithiol 10 (Figure 1 ). GliN-catalyzed N-4 methylation of 10, followed by epoxidation of the phenyl group, catalyzed by the putative cytochrome P450s GliC or GliF, and epoxide opening with N-1, would yield reduced gliotoxin 3, which has been reported to undergo GliT, FAD, and O 2 -mediated oxidation to form gliotoxin 1 (Figure 1) (Wang et al., 2009; Schrettl et al., 2010; Scharf et al., 2010) . It is conceivable that the GliJ-and GliI-catalyzed reactions to expose the thiol groups in 3 may occur after N-4 methylation and epoxidation/epoxide opening, given the potential deleterious effects of intracellular gliotoxin, due to the presence of reactive thiols or a disulfide bridge capable of redox cycling (Waring et al., 1995; Bernardo et al., 2003; Gardiner et al., 2005b; Nishida et al., 2005) .
GSTs form homodimers (Sheehan et al., 2001) . Nonreducing SDS-PAGE analysis of rGliG identified homodimeric and monomeric forms, indicating that rGliG is, like other GSTs, homodimeric. Activity of rGliG toward EPNP, CDNB, and DCNB was observed, verifying the predicted GST activity of this enzyme. GliG exhibited higher activity toward both CDNB and DCNB than GstA, GstB, and GstC, previously cloned and expressed from A. fumigatus (Burns et al., 2005) . In fact, GstA, GstB, and GstC did not have detectable activity toward DCNB. Interestingly, a low but detectable glutathione reductase activity was observed for rGliG. Although rGliG did not exhibit glutathione peroxidase activity, this was detectable for positive control enzyme, A. fumigatus GstB (Burns et al., 2005) . Thus, it appears that rGliG exhibits a different pattern of reactivity to other A. fumigatus GSTs.
In conclusion we show that the GST, GliG, is involved in the biosynthesis of gliotoxin and not in self-resistance to this ETP. GliG-mediated addition of glutathione to acyl iminecontaining intermediates is proposed to be a key step in gliotoxin biosynthesis. To our knowledge, this is the first time that such a reaction has been suggested to play a pivotal function in ETP biosynthesis.
SIGNIFICANCE
Most studies pertaining to gliotoxin have focused on its role in mediating fungal virulence and the mechanisms of action by which this occurs. Although the roles of GliP and GliT in the first and last steps of gliotoxin biosynthesis, respectively, have been investigated in vitro and in vivo, to our knowledge, no further information on gliotoxin biosynthesis has been forthcoming. Here, we demonstrate that disruption of gliG within the gliotoxin biosynthetic gene cluster of A. fumigatus results in the secretion of a shunt metabolite from the gliotoxin biosynthetic pathway, 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. We show that GliG exhibits glutathione S-transferase activity, and the presence of a hydroxyl group at C-6 of the shunt metabolite leads us to propose that elimination of water from N-1/C-6 of a C-6 hydroxylated piperazine-2,5-dione intermediate yields an acyl imine, which undergoes GliG-mediated addition of glutathione. A similar hydroxylation, elimination, glutathione addition sequence is proposed to occur at C-3 of the piperazine-2,5-dione. We propose that the subsequent peptidase activity of GliJ, and PLP-dependent thiol elimination catalyzed by GliI, results in formation of a dithiol intermediate. In the absence of GliG, the shunt metabolite is likely formed due to the metabolic instability of the presumed 6-benzyl-6-hydroxy-3-hydroxymethylpiperazine-2,5-dione biosynthetic intermediate. We propose that N-4 methylation and epoxidation of the phenyl group occur after thiolation because both modifications are absent in 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. GliG does not play a role in self-protection of A. fumigatus against exogenous gliotoxin, unlike GliT, a gliotoxin reductase/oxidase, which has been demonstrated to be the key enzyme responsible for this phenomenon. Overall, these results elucidate a catalytic role for GliG in gliotoxin biosynthesis. (Table S1 ) were grown at 37 C in Aspergillus minimal media (AMM). AMM contained 1% (w/v) glucose as carbon-source, 20 mM L-glutamine as nitrogen-source, and trace elements according to Pontecorvo et al. (1953) .
Gene Deletion and Complementation in A. fumigatus For generating DgliG strains, the bipartite marker technique was used . Primer details are provided in Table S2 . Briefly, A. fumigatus strains AF293 and akuB were cotransformed with two DNA constructs, each containing an incomplete fragment of a pyrithiamine resistance gene (ptrA) (Tilburn et al., 2005; Kubodera et al., 2000) fused to 1.0 and 1.2 kb of gliG-flanking sequences, respectively. Further details and the gliG complementation strategy are given in Supplemental Experimental Procedures.
Northern Analysis RNA was isolated using TRI-Reagent (Sigma-Aldrich). Equal concentrations of total RNA (10 mg) were size separated on 1.2% (w/v) agarose-2.2 M formaldehyde gels and blotted onto Hybond N+ membranes (Amersham Biosciences).
The hybridization probes used in this study were generated by PCR using primers ogliG-7 and ogliG-8.
Phenotypic Analysis of A. fumigatus AF293 Wild-Type and DgliG Strains Relative sensitivities of A. fumigatus wild-type, DgliG, and gliG c were assessed against gliotoxin (10-50 mg/ml) (Schrettl et al., 2010; Losada et al., 2009) , voriconazole (0.15 and 0.25 mg/ml), H 2 O 2 (1, 2, and 5 mM), and amphotericin B (1, 2, and 5 mg/ml). See Supplemental Experimental Procedures for further details.
Virulence Model G. mellonella larvae (n = 10) were inoculated into the hind pro-leg with 10 6
A. fumigatus conidia in 20 ml (per larva) (Reeves et al., 2004) . Mortality rates were recorded for 72 hr postinjection. See Supplemental Experimental Procedures for further details.
Analysis of Gliotoxin Production
To analyze gliotoxin production, A. fumigatus wild-type, DgliG and complemented strains were grown at 37 C for 72 hr in AMM. Supernatants were chloroform extracted, and fractions were evaporated to complete dryness, followed by resolubilization in methanol and analysis by RP-HPLC or LC-MS, as described by Reeves et al. (2004) and Schrettl et al. (2010) .
LC-MS Analysis
Electrospray MS analysis of gliotoxin was performed as described previously (Schrettl et al., 2010) . LC-ToF MS was performed on an Agilent HPLC 1200 series and injected (injection volume: 10 ml) using electrospray ionization inputted into a time-of-flight chamber (Agilent). The LC separation was done on a XDB C 18 column (4.6 3 150 mm) using a water/acetonitrile (both containing 0.1% [v/v] formic acid) gradient at a flow rate of 0.5 ml/min. The gradient was started at 50% (v/v) acetonitrile, which was increased to 100% acetonitrile in 10 min; 100% acetonitrile was maintained for 5 min before the gradient was returned to starting conditions. Spectra were collected at 0.99 spectra per second.
Extraction and Purification of the Gliotoxin Shunt Metabolite
A. fumigatus DgliG cultures were grown at 37 C for 48 hr in AMM. Culture supernatants were extracted twice with chloroform. Organic extracts were evaporated to dryness and resolubilized in methanol. A layer of the methanolic solution was applied to preparative TLC plates (Silica gel, UV 254 nm, 20 3 20 cm, 50 mm; Analtech, Newark, DE, USA). Plates were developed with two runs of dichloromethane:methanol (97:3 containing 0.5% [v/v] acetic acid). The silica in the area containing metabolite M12.3 was collected and washed in acetone (20 ml), dried, and the resultant material was resolubilized in either CD 3 CN or CDCl 3 for NMR analysis.
